D, C., S, T., D, C., JS, L., AJ, N., R, S., & S, B. (2024). Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B. Digestive diseases and sciences, 69(4), 1496. https://doi.org/10.1007/s10620-024-08354-4
Chicago Style (17th ed.) CitationD, Con, Tu S, Clayton-Chubb D, Lubel JS, Nicoll AJ, Sawhney R, and Bloom S. "Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B." Digestive Diseases and Sciences 69, no. 4 (2024): 1496. https://doi.org/10.1007/s10620-024-08354-4.
MLA (9th ed.) CitationD, Con, et al. "Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B." Digestive Diseases and Sciences, vol. 69, no. 4, 2024, p. 1496, https://doi.org/10.1007/s10620-024-08354-4.